WHO ICTRP trial
Feasibility and safety analysis of laryngeal mask implantation induced by…
ChiCTR2100052136 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100052136 |
|---|---|
| Public title | Feasibility and safety analysis of laryngeal mask implantation induced by remazolam combined with remifentanil |
| Scientific title | Feasibility and safety analysis of laryngeal mask implantation induced by remazolam combined with remifentanil |
| Primary sponsor | Rinmin Hospital of Wuhan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Induction of General anesthesia |
| Interventions | Experimental group:0.3mg/kgRemimazolam+1.2µg/kgremifentanial;Control group:2.0mg/kgPropofol+1.2µg/kgremifentanial |
| Registration date | Oct 20, 2021 |
| Target size | Experimental group:39;Control group:39 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: